Company overview
Ori Biotech offers the IRO platform, a proprietary system that automates, standardizes, and scales cell and gene therapy (CGT) manufacturing, particularly for cell therapies like CAR-T. The compact, flexible platform reduces costs, processing times, and labor while improving quality through integrated hardware, software, and data services. It supports end-to-end workflows from preclinical development to commercial scale and integrates with partner technologies for closed, efficient processing.
Ori Biotech is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing, Lab Equipment & Instruments partner serving United States & Americas. Core focus areas include ori biotech, cell therapy manufacturing, gene therapy platform, cgt automation, car-t production.
Industry categories: CDMO & Manufacturing, Lab Equipment & Instruments. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Ori Biotech include Automation — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://oribiotech.com
- Categories
- CDMO & Manufacturing, Lab Equipment & Instruments
- Markets served
- United States & Americas
- Keywords
- ori biotech, cell therapy manufacturing, gene therapy platform, cgt automation, car-t production
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What capabilities does Ori Biotech's IRO platform provide for CGT manufacturing?
- The IRO platform automates and standardizes cell therapy manufacturing, including novel bioreactors, cloud-native digital data capture every seven seconds, and flexible scalability via stackable microwave-sized devices, supporting CAR-T and other processes from preclinical to commercial scale.
- What regulatory and quality features does the IRO platform offer?
- The platform enables closed, automated workflows that improve quality, reduce contamination risks, and standardize processes, with demonstrated integration into validated systems like Fresenius Kabi's Cue and Lovo for efficient upstream and downstream processing.
- In which geographies does Ori Biotech operate and support manufacturing?
- Ori Biotech is based in London (UK), New Jersey, and Philadelphia (US), with data from internal and partner sites worldwide, enabling global access to scalable CGT manufacturing.
Related editorial coverage
- ASGCT 2024: Gene Therapy Advancements Day 1 Roundup
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
